Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

9(90.0%)

Phase 1

1(10.0%)

10Total

N/A(9)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT05462405Not ApplicableActive Not Recruiting

Evaluation of Sympathetic Activity Effects by the BackBeat Medical Cardiac Neuromodulation Therapy (CNT).

Role: lead

NCT05719454Not ApplicableRecruiting

Novel Setup Algorithm for Cardiac Neuromodulation Therapy

Role: lead

NCT05345925Not ApplicableUnknown

PV Loops With CNT in Multiple Pacing Sites

Role: lead

NCT02909868Not ApplicableUnknown

CS-03 Pressure-Volume Loop Sub-study With RV Lead Positioning

Role: lead

NCT03757377Not ApplicableUnknown

Moderato System in Patients With Hypertension

Role: lead

NCT02837445Not ApplicableUnknown

Moderato System: A Double-Blind Randomized Trial Ver 1.1

Role: lead

NCT05086523Phase 1Unknown

Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study

Role: lead

NCT04463121Not ApplicableUnknown

Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06)

Role: lead

NCT04573699Unknown

Cardiac Neuromodulation for Heart Failure

Role: lead

NCT02282033Not ApplicableCompleted

Safety and Performance Study of the Moderato System

Role: lead

NCT02382484Not ApplicableCompleted

Impact of Pacing Site and AV Delay on Blood Pressure in Hypertensive Patients

Role: lead

All 11 trials loaded